{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T22:30:44Z","timestamp":1795213844311,"version":"4.10.3"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,4]],"date-time":"2022-07-04T00:00:00Z","timestamp":1656892800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,4]],"date-time":"2022-07-04T00:00:00Z","timestamp":1656892800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004047","name":"Karolinska Institute","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Tooth extraction is a risk factor for the development of osteonecrosis of the jaw following treatment with antiresorptive drugs (ARDs), but not all extraction sites develop this pathology. Therefore, we aimed to identify local radiographic predictors of Medication-Related Osteonecrosis of the Jaw (MRONJ) in panoramic images of oncologic patients undergoing tooth extraction. Based on a retrospective longitudinal cohort study design, patients were included if undergoing one or more tooth extraction, with at least one administration of ARDs, and presence of pre- and post-operative panoramic radiographs. After data collection, blinded and independent observations were performed. Eleven distinct imaging-related parameters were assessed preoperatively and five postoperatively, at each extraction site. A case\u2013control and subgroup analysis assessing MRONJ development was performed. Significance level is set to 0.05 (5%). A total of 77 oncologic patients were selected, undergoing 218 tooth extractions, from which 63 teeth (29%) in 39 patients (51%) developed MRONJ. Results showed that patients developed significantly more MRONJ with longer ARD treatment (<jats:italic>p<\/jats:italic>\u2009=\u20090.057), teeth with absent and incomplete endodontic fillings with caries, widened periodontal ligament space and\/or periapical lesions (<jats:italic>p<\/jats:italic>\u2009=\u20090.005), and sclerotic and heterogenous bone patterns (<jats:italic>p<\/jats:italic>\u2009=\u20090.005). In conclusion, tooth extraction sites presenting with infections and bone sclerosis are at higher risk to develop MRONJ.<\/jats:p>","DOI":"10.1038\/s41598-022-15254-y","type":"journal-article","created":{"date-parts":[[2022,7,4]],"date-time":"2022-07-04T15:03:01Z","timestamp":1656946981000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Radiographic predictors for MRONJ in oncologic patients undergoing tooth extraction"],"prefix":"10.1038","volume":"12","author":[{"given":"Catalina","family":"Moreno-Rabi\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Lapauw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo","family":"Ga\u00eata-Araujo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Ferreira-Leite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wim","family":"Coucke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"van den Wyngaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinhilde","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,4]]},"reference":[{"key":"15254_CR1","doi-asserted-by":"publisher","first-page":"257","DOI":"10.2217\/fon.13.211","volume":"10","author":"G Campisi","year":"2014","unstructured":"Campisi, G. et al. Epidemiology, clinical manifestations, risk reduction and treatment strategies of jaw osteonecrosis in cancer patients exposed to antiresorptive agents. Future Oncol. 10, 257\u2013275 (2014).","journal-title":"Future Oncol."},{"key":"15254_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbo.2018.10.004","volume":"15","author":"S D\u2019Oronzo","year":"2019","unstructured":"D\u2019Oronzo, S., Coleman, R., Brown, J. & Silvestris, F. Metastatic bone disease: Pathogenesis and therapeutic options. J. Bone Oncol. 15, 100205 (2019).","journal-title":"J. Bone Oncol."},{"key":"15254_CR3","doi-asserted-by":"publisher","first-page":"6243s","DOI":"10.1158\/1078-0432.CCR-06-0931","volume":"12","author":"RE Coleman","year":"2006","unstructured":"Coleman, R. E. Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin. Cancer Res. 12, 6243s\u20136249s (2006).","journal-title":"Clin. Cancer Res."},{"key":"15254_CR4","doi-asserted-by":"publisher","first-page":"e260","DOI":"10.4317\/medoral.21001","volume":"21","author":"C Gavald\u00e1","year":"2016","unstructured":"Gavald\u00e1, C., Bag\u00e1n, J.-V., Gavalda, C. & Bagan, J. Concept, diagnosis and classification of bisphosphonate-associated osteonecrosis of the jaws: a review of the literature. Med. Oral Patol. Oral Cir. Bucal 21, e260\u2013e270 (2016).","journal-title":"Med. Oral Patol. Oral Cir. Bucal"},{"key":"15254_CR5","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/S0278-2391(09)00013-5","volume":"67","author":"SL Ruggiero","year":"2009","unstructured":"Ruggiero, S. L. et al. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws\u20142009 update. J. Oral Maxillofac. Surg. 67, 2\u201312 (2009).","journal-title":"J. Oral Maxillofac. Surg."},{"key":"15254_CR6","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","volume":"72","author":"SL Ruggiero","year":"2014","unstructured":"Ruggiero, S. L. et al. American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw\u20142014 update. J. Oral Maxillofac. Surg. 72, 1938\u20131956 (2014).","journal-title":"J. Oral Maxillofac. Surg."},{"key":"15254_CR7","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1111\/odi.13160","volume":"25","author":"M Schiodt","year":"2019","unstructured":"Schiodt, M. et al. Workshop of European task force on medication-related osteonecrosis of the jaw-current challenges. Oral Dis. 25, 1815\u20131821 (2019).","journal-title":"Oral Dis."},{"key":"15254_CR8","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.ctrv.2018.06.007","volume":"69","author":"S Otto","year":"2018","unstructured":"Otto, S., Pautke, C., Van den Wyngaert, T., Niepel, D. & Schi\u00f8dt, M. Medication-related osteonecrosis of the jaw: prevention, diagnosis and management in patients with cancer and bone metastases. Cancer Treat. Rev. 69, 177\u2013187 (2018).","journal-title":"Cancer Treat. Rev."},{"key":"15254_CR9","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.bjoms.2009.08.030","volume":"48","author":"KHH Taylor","year":"2010","unstructured":"Taylor, K. H. H., Middlefell, L. S. S. & Mizen, K. D. D. Osteonecrosis of the jaws induced by anti-RANK ligand therapy. Br. J. Oral Maxillofac. Surg. 48, 221\u2013223 (2010).","journal-title":"Br. J. Oral Maxillofac. Surg."},{"key":"15254_CR10","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1111\/odi.13294","volume":"26","author":"O Nicolatou-Galitis","year":"2020","unstructured":"Nicolatou-Galitis, O. et al. Alveolar bone histological necrosis observed prior to extractions in patients, who received bone-targeting agents. Oral Dis. 26, 955\u2013966 (2020).","journal-title":"Oral Dis."},{"key":"15254_CR11","unstructured":"Ga\u00eata-Araujo, H. et al. Why do some extraction sites develop medication-related osteonecrosis of the jaw and others do not? A within-patient study assessing radiographic predictors. Int. J. Oral Implantol. (Berl., Ger.) 14, 87\u201398 (2021)."},{"key":"15254_CR12","first-page":"1","volume":"2017","author":"CL Cardoso","year":"2017","unstructured":"Cardoso, C. L. et al. Radiographic findings in patients with medication-related osteonecrosis of the jaw. Int. J. Dent. 2017, 1\u20136 (2017).","journal-title":"Int. J. Dent."},{"key":"15254_CR13","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1016\/j.ijsu.2014.07.014","volume":"12","author":"JP Vandenbroucke","year":"2014","unstructured":"Vandenbroucke, J. P. et al. Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration. Int. J. Surg. 12, 1500\u20131524 (2014).","journal-title":"Int. J. Surg."},{"key":"15254_CR14","first-page":"360","volume":"37","author":"AJ Viera","year":"2005","unstructured":"Viera, A. J. & Garrett, J. M. Understanding interobserver agreement: the kappa statistic. Fam. Med. 37, 360\u2013363 (2005).","journal-title":"Fam. Med."},{"key":"15254_CR15","doi-asserted-by":"publisher","first-page":"2973","DOI":"10.1007\/s00784-020-03423-0","volume":"24","author":"C Moreno-Rabi\u00e9","year":"2020","unstructured":"Moreno-Rabi\u00e9, C., Ga\u00eata-Araujo, H., Oliveira-Santos, C., Politis, C. & Jacobs, R. Early imaging signs of the use of antiresorptive medication and MRONJ: a systematic review. Clin. Oral Investig. 24, 2973\u20132989 (2020).","journal-title":"Clin. Oral Investig."},{"key":"15254_CR16","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1007\/s00774-020-01195-x","volume":"39","author":"N Ueda","year":"2021","unstructured":"Ueda, N. et al. Oral risk factors associated with medication-related osteonecrosis of the jaw in patients with cancer. J. Bone Miner. Metab. 39, 623\u2013630 (2021).","journal-title":"J. Bone Miner. Metab."},{"key":"15254_CR17","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1093\/annonc\/mdn554","volume":"20","author":"MA Dimopoulos","year":"2009","unstructured":"Dimopoulos, M. A. et al. Reduction of osteonecrosis of the jaw (ONJ) after implementation of preventive measures in patients with multiple myeloma treated with zoledronic acid. Ann. Oncol. Off. J. Eur. Soc. Med. Oncol. 20, 117\u2013120 (2009).","journal-title":"Ann. Oncol. Off. J. Eur. Soc. Med. Oncol."},{"key":"15254_CR18","doi-asserted-by":"crossref","unstructured":"Ripamonti, C. I. et al. Decreased occurrence of osteonecrosis of the jaw after implementation of dental preventive measures in solid tumour patients with bone metastases treated with bisphosphonates. The experience of the National Cancer Institute of Milan. Ann. Oncol. Off. J. Eur. Soc. Med. Oncol. 20, 137\u2013145 (2009).","DOI":"10.1093\/annonc\/mdn526"},{"key":"15254_CR19","doi-asserted-by":"publisher","first-page":"20160065","DOI":"10.1259\/dmfr.20160065","volume":"45","author":"C Klingelh\u00f6ffer","year":"2016","unstructured":"Klingelh\u00f6ffer, C., Klingelh\u00f6ffer, M., M\u00fcller, S., Ettl, T. & Wahlmann, U. Can dental panoramic radiographic findings serve as indicators for the development of medication-related osteonecrosis of the jaw?. Dentomaxillofac. Radiol. 45, 20160065 (2016).","journal-title":"Dentomaxillofac. Radiol."},{"key":"15254_CR20","doi-asserted-by":"crossref","unstructured":"Guo, Y., Wang, D., Wang, Y., Peng, X. & Guo, C. Imaging features of medicine-related osteonecrosis of the jaws: comparison between panoramic radiography and computed tomography. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. 122, e69\u2013e76 (2016).","DOI":"10.1016\/j.oooo.2016.04.007"},{"key":"15254_CR21","doi-asserted-by":"publisher","DOI":"10.5037\/jomr.2010.1203","volume":"1","author":"J Olutayo","year":"2010","unstructured":"Olutayo, J. et al. Bisphosphonate-related osteonecrosis of the jaw bone: radiological pattern and the potential role of CBCT in early diagnosis. J. Oral Maxillofac. Res. 1, e3 (2010).","journal-title":"J. Oral Maxillofac. Res."},{"key":"15254_CR22","doi-asserted-by":"publisher","first-page":"2811","DOI":"10.1007\/s00520-020-05855-6","volume":"29","author":"R Querrer","year":"2021","unstructured":"Querrer, R. et al. Differences between bisphosphonate-related and denosumab-related osteonecrosis of the jaws: a systematic review. Support. Care Cancer 29, 2811\u20132820 (2021).","journal-title":"Support. Care Cancer"},{"key":"15254_CR23","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.bjoms.2014.04.009","volume":"52","author":"A Bedogni","year":"2014","unstructured":"Bedogni, A. et al. Staging of osteonecrosis of the jaw requires computed tomography for accurate definition of the extent of bony disease. Br. J. Oral Maxillofac. Surg. 52, 603\u2013608 (2014).","journal-title":"Br. J. Oral Maxillofac. Surg."},{"key":"15254_CR24","doi-asserted-by":"crossref","unstructured":"Bedogni, A., Fusco, V., Agrillo, A. & Campisi, G. Learning from experience. Proposal of a refined definition and staging system for bisphosphonate-related osteonecrosis of the jaw (BRONJ). Oral Dis. 18, 621\u20133 (2012).","DOI":"10.1111\/j.1601-0825.2012.01903.x"},{"key":"15254_CR25","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.jcms.2014.01.012","volume":"42","author":"H Hamada","year":"2014","unstructured":"Hamada, H., Matsuo, A., Koizumi, T., Satomi, T. & Chikazu, D. A simple evaluation method for early detection of bisphosphonate-related osteonecrosis of the mandible using computed tomography. J. Cranio-Maxillofac. Surg. 42, 924\u2013929 (2014).","journal-title":"J. Cranio-Maxillofac. Surg."},{"key":"15254_CR26","doi-asserted-by":"crossref","unstructured":"Torres, S. R. et al. Mandibular inferior cortical bone thickness on panoramic radiographs in patients using bisphosphonates. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. 119, 584\u201392 (2015).","DOI":"10.1016\/j.oooo.2015.02.005"},{"key":"15254_CR27","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.joms.2013.09.008","volume":"72","author":"TL Aghaloo","year":"2014","unstructured":"Aghaloo, T. L., Dry, S. M., Mallya, S. & Tetradis, S. Stage 0 osteonecrosis of the jaw in a patient on denosumab. J. Oral Maxillofac. Surg. 72, 702\u2013716 (2014).","journal-title":"J. Oral Maxillofac. Surg."},{"key":"15254_CR28","doi-asserted-by":"crossref","unstructured":"\u015eahin, O. et al. Comparison of findings of radiographic and fractal dimension analyses on panoramic radiographs of patients with early-stage and advanced-stage medication-related osteonecrosis of the jaw. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. 128, 78\u201386 (2019).","DOI":"10.1016\/j.oooo.2019.03.002"},{"key":"15254_CR29","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.1016\/j.joms.2010.05.003","volume":"68","author":"M Hutchinson","year":"2010","unstructured":"Hutchinson, M. et al. Radiographic findings in bisphosphonate-treated patients with stage 0 disease in the absence of bone exposure. J. Oral Maxillofac. Surg. 68, 2232\u20132240 (2010).","journal-title":"J. Oral Maxillofac. Surg."},{"key":"15254_CR30","doi-asserted-by":"publisher","first-page":"3087","DOI":"10.1007\/s00784-020-03632-7","volume":"25","author":"N Ueda","year":"2021","unstructured":"Ueda, N. et al. Does inflammatory dental disease affect the development of medication-related osteonecrosis of the jaw in patients using high-dose bone-modifying agents?. Clin. Oral Investig. 25, 3087\u20133093 (2021).","journal-title":"Clin. Oral Investig."},{"key":"15254_CR31","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.amjmed.2010.04.033","volume":"123","author":"S Fedele","year":"2010","unstructured":"Fedele, S. et al. Nonexposed variant of bisphosphonate-associated osteonecrosis of the jaw: a case series. Am. J. Med. 123, 1060\u20131064 (2010).","journal-title":"Am. J. Med."},{"key":"15254_CR32","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.joms.2008.12.002","volume":"67","author":"K Arce","year":"2009","unstructured":"Arce, K., Assael, L. A., Weissman, J. L. & Markiewicz, M. R. Imaging findings in bisphosphonate-related osteonecrosis of jaws. J. Oral Maxillofac. Surg. 67, 75\u201384 (2009).","journal-title":"J. Oral Maxillofac. Surg."},{"key":"15254_CR33","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1200\/jop.2006.2.1.7","volume":"2","author":"S Ruggiero","year":"2006","unstructured":"Ruggiero, S. et al. Practical guidelines for the prevention, diagnosis, and treatment of osteonecrosis of the jaw in patients with cancer. J. Oncol. Pract. 2, 7\u201314 (2006).","journal-title":"J. Oncol. Pract."},{"key":"15254_CR34","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.joen.2007.10.017","volume":"34","author":"C de Chevigny","year":"2008","unstructured":"de Chevigny, C. et al. Treatment outcome in endodontics: the toronto study\u2014phase 4: initial treatment. J. Endod. 34, 258\u2013263 (2008).","journal-title":"J. Endod."},{"key":"15254_CR35","doi-asserted-by":"publisher","first-page":"20160260","DOI":"10.1259\/dmfr.20160260","volume":"46","author":"VS Koth","year":"2017","unstructured":"Koth, V. S., Figueiredo, M. A., Salum, F. G. & Cherubini, K. Interrelationship of clinical, radiographic and haematological features in patients under bisphosphonate therapy. Dentomaxillofac. Radiol. 46, 20160260 (2017).","journal-title":"Dentomaxillofac. Radiol."},{"key":"15254_CR36","doi-asserted-by":"publisher","first-page":"656","DOI":"10.3109\/00016357.2014.887772","volume":"72","author":"A Matsuo","year":"2014","unstructured":"Matsuo, A. et al. Characteristics of the early stages of intravenous bisphosphonate-related osteonecrosis of the jaw in patients with breast cancer. Acta Odontol. Scand. 72, 656\u2013663 (2014).","journal-title":"Acta Odontol. Scand."},{"key":"15254_CR37","doi-asserted-by":"crossref","unstructured":"Nicolatou-Galitis, O. et al. Medication-related osteonecrosis of the jaw: definition and best practice for prevention, diagnosis, and treatment. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. 127, 117\u2013135 (2019).","DOI":"10.1016\/j.oooo.2018.09.008"},{"key":"15254_CR38","doi-asserted-by":"publisher","first-page":"3483","DOI":"10.1007\/s00520-013-1934-0","volume":"21","author":"T Van den Wyngaert","year":"2013","unstructured":"Van den Wyngaert, T. et al. Prospective observational study of treatment pattern, effectiveness and safety of zoledronic acid therapy beyond 24 months in patients with multiple myeloma or bone metastases from solid tumors. Support. Care Cancer 21, 3483\u20133490 (2013).","journal-title":"Support. Care Cancer"},{"key":"15254_CR39","doi-asserted-by":"publisher","first-page":"e771","DOI":"10.4317\/jced.56837","volume":"12","author":"O \u015eahin","year":"2020","unstructured":"\u015eahin, O., Tatar, B., Ekmekcio\u011flu, C., Aliyev, T. & Odaba\u015f\u0131, O. Prevention of medication related osteonecrosis of the jaw after dentoalveolar surgery: an institution\u2019s experience. J. Clin. Exp. Dent. 12, e771\u2013e776 (2020).","journal-title":"J. Clin. Exp. Dent."},{"key":"15254_CR40","first-page":"220","volume":"51","author":"A Spanou","year":"2020","unstructured":"Spanou, A. et al. Primary wound closure and perioperative antibiotic therapy for prevention of bisphosphonate-related osteonecrosis of the jaw after tooth extraction. Quintessence Int. 51, 220\u2013228 (2020).","journal-title":"Quintessence Int."},{"key":"15254_CR41","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1016\/j.joms.2021.05.031","volume":"79","author":"R Pippi","year":"2021","unstructured":"Pippi, R., Giuliani, U., Tenore, G., Pietrantoni, A. & Romeo, U. What is the risk of developing medication-related osteonecrosis in patients with extraction sockets left to heal by secondary intention? A retrospective case series study. J. Oral Maxillofac. Surg. 79, 2071\u20132077 (2021).","journal-title":"J. Oral Maxillofac. Surg."},{"key":"15254_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2021\/4948139","volume":"2021","author":"M Miranda","year":"2021","unstructured":"Miranda, M. et al. The role of platelet-rich fibrin (PRF) in the prevention of medication-related osteonecrosis of the jaw (MRONJ). Biomed Res. Int. 2021, 1\u20138 (2021).","journal-title":"Biomed Res. Int."},{"key":"15254_CR43","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1007\/s00784-016-2004-z","volume":"21","author":"T Asaka","year":"2017","unstructured":"Asaka, T. et al. Platelet-rich fibrin may reduce the risk of delayed recovery in tooth-extracted patients undergoing oral bisphosphonate therapy: a trial study. Clin. Oral Investig. 21, 2165\u20132172 (2017).","journal-title":"Clin. Oral Investig."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-15254-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-15254-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-15254-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T06:06:31Z","timestamp":1669356391000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-15254-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,4]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["15254"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-15254-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,4]]},"assertion":[{"value":"17 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11280"}}